As of | ||||
September 30, 2021 | December 31, 2020 | |||
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 65,768 | $ | 49,242 |
Accounts receivable and other, net | 23,284 | 31,740 | ||
Prepaid expenses and other current assets | 7,053 | 3,800 | ||
Total current assets | 96,105 | 84,782 | ||
Property and equipment, net | 4,331 | 5,321 | ||
Restricted cash, non-current | - | 1,144 | ||
Deferred commissions | 7,092 | 9,556 | ||
Deferred professional service costs | 3,624 | 4,462 | ||
Intangible assets, net | 4,756 | 7,930 | ||
Goodwill | 41,485 | 41,485 | ||
Operating lease right-of-use assets, net | 6,860 | 10,238 | ||
Other assets | 106 | 1,855 | ||
Total assets | $ | 164,359 | $ | 166,773 |
Liabilities and stockholders' equity | ||||
Current liabilities: | ||||
Accounts payable | $ | 4,543 | $ | 5,145 |
Accrued expenses and other current liabilities | 3,997 | 7,898 | ||
Accrued compensation | 9,398 | 8,633 | ||
Deferred revenue | 9,703 | 6,848 | ||
Operating lease liabilities | 5,004 | 5,789 | ||
Total current liabilities | 32,645 | 34,313 | ||
Deferred revenue, non-current | 188 | 663 | ||
Operating lease liabilities, non-current | 3,950 | 7,446 | ||
Other liabilities, non-current | 485 | 485 | ||
Total liabilities | 37,268 | 42,907 | ||
Stockholders' equity | 127,091 | 123,866 | ||
Total liabilities and stockholders' equity | $ | 164,359 | $ | 166,773 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2021 | 2020 | 2021 | 2020 | |||||
Revenue: | ||||||||
Subscription | $ | 31,613 | $ | 34,069 | $ | 94,851 | $ | 106,741 |
Professional services and other | 3,163 | 1,009 | 10,587 | 2,882 | ||||
Total revenue, net | 34,776 | 35,078 | 105,438 | 109,623 | ||||
Cost of revenue: | ||||||||
Cost of subscription(1)
| 8,081 | 8,013 | 24,157 | 27,064 | ||||
Cost of professional services and other(1)
| 3,675 | 3,874 | 12,513 | 12,057 | ||||
Total cost of revenue | 11,756 | 11,887 | 36,670 | 39,121 | ||||
Gross profit | 23,020 | 23,191 | 68,768 | 70,502 | ||||
Operating expenses: | ||||||||
Sales and marketing(1)
| 7,079 | 6,158 | 21,200 | 24,313 | ||||
Research and development(1)
| 11,631 | 11,182 | 36,060 | 38,047 | ||||
General and administrative(1)
| 6,195 | 6,341 | 18,927 | 19,257 | ||||
Goodwill impairment | - | - | - | 50,300 | ||||
Total operating expenses | 24,905 | 23,681 | 76,187 | 131,917 | ||||
Operating loss | (1,885) | (490) | (7,419) | (61,415) | ||||
Other income, net | 132 | 43 | 281 | 429 | ||||
Income before income taxes | (1,753) | (447) | (7,138) | (60,986) | ||||
Provision for income taxes | 279 | - | 279 | - | ||||
Net loss | $ | (2,032) | $ | (447) | $ | (7,417) | $ | (60,986) |
Net loss per share, basic and diluted | $ | (0.01) | $ | - | $ | (0.05) | $ | (0.41) |
Weighted-average shares used to compute basic and diluted net loss per share
| 161,103 | 152,146 | 158,961 | 150,372 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2021 | 2020 | 2021 | 2020 | |||||
Cost of revenue: | ||||||||
Cost of subscription | $ | 256 | $ | 224 | $ | 735 | $ | 598 |
Cost of professional services and other | 145 | 171 | 565 | 431 | ||||
Sales and marketing | 483 | 282 | 1,275 | 1,702 | ||||
Research and development | 1,001 | 1,026 | 3,130 | 3,503 | ||||
General and administrative | 1,315 | 1,401 | 3,772 | 3,325 |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||
2021 | 2020 | 2021 | 2020 | |||||
Operating activities: | ||||||||
Net loss | $ | (2,032) | $ | (447) | $ | (7,417) | $ | (60,986) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
| ||||||||
Depreciation and amortization | 1,674 | 1,763 | 4,913 | 4,907 | ||||
Goodwill impairment | - | - | - | 50,300 | ||||
Stock-based compensation | 3,200 | 3,104 | 9,477 | 9,559 | ||||
Amortization of deferred commissions | 1,372 | 1,598 | 3,940 | 5,517 | ||||
Amortization of deferred professional service costs | 568 | 760 | 1,715 | 2,417 | ||||
Non-cash operating lease expense | 1,145 | 1,134 | 3,377 | 3,765 | ||||
Other | 13 | - | 32 | 2 | ||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable and other, net | (1,549) | 2,704 | 8,456 | 926 | ||||
Deferred commissions | (1,283) | (476) | (1,476) | (1,396) | ||||
Deferred professional service costs | (298) | (289) | (819) | (918) | ||||
Prepaid expenses and other assets | 1,663 | 1,066 | (360) | 242 | ||||
Accounts payable | 808 | (3,847) | (650) | (14,048) | ||||
Operating lease liabilities | (1,476) | (1,570) | (4,281) | (4,186) | ||||
Accrued expenses and other liabilities | (73) | (1,065) | (2,016) | (2,576) | ||||
Deferred revenue | (189) | (2,862) | 2,380 | (100) | ||||
Accrued compensation | 2,294 | 1,165 | 765 | (1,949) | ||||
Net cash provided by (used in) operating activities | 5,837 | 2,738 | 18,036 | (8,524) | ||||
Investing activities: | ||||||||
Purchase of property and equipment | (456) | (132) | (701) | (3,431) | ||||
Purchase of marketable securities | - | - | - | (2,994) | ||||
Sales of marketable securities | - | - | - | 2,001 | ||||
Maturities of marketable securities | - | - | - | 17,400 | ||||
Net cash (used in) provided by investing activities | (456) | (132) | (701) | 12,976 | ||||
Financing activities: | ||||||||
Proceeds from exercise of stock options | 259 | 23 | 485 | 178 | ||||
Proceeds from ESPP offering | 390 | 185 | 623 | 371 | ||||
Principal payments on long-term debt | (465) | (465) | (1,395) | (1,395) | ||||
Final payment on term loan | (490) | - | (490) | - | ||||
Net cash used in financing activities | (306) | (257) | (777) | (846) | ||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (13) | - | (32) | - | ||||
Net increase in cash, cash equivalents and restricted cash
| 5,062 | 2,349 | 16,526 | 3,606 | ||||
Cash, cash equivalents and restricted cash at beginning of period
| 61,850 | 45,599 | 50,386 | 44,342 | ||||
Cash, cash equivalents and restricted cash at end of period | $ | 66,912 | $ | 47,948 | $ | 66,912 | $ | 47,948 |
Reconciliation of cash, cash equivalents and restricted cash:
| ||||||||
Cash and cash equivalents | $ | 65,768 | $ | 46,804 | $ | 65,768 | $ | 46,804 |
Restricted cash included in Prepaid expenses and other current assets | 1,144 | - | 1,144 | - | ||||
Restricted cash, non-current | - | 1,144 | - | 1,144 | ||||
Total cash, cash equivalents and restricted cash | $ | 66,912 | $ | 47,948 | $ | 66,912 | $ | 47,948 |
Three Months Ended | Nine Months Ended | |||||||||
September 30, 2021 | June 30, 2021 | September 30, 2020 | September 30, 2021 | September 30, 2020 | ||||||
Gross profit: | ||||||||||
GAAP gross profit subscription | $ | 23,532 | $ | 23,151 | $ | 26,056 | $ | 70,694 | $ | 79,677 |
Stock-based compensation | 256 | 222 | 224 | 735 | 598 | |||||
Amortization of internal-use software | 79 | 79 | 79 | 237 | 184 | |||||
Amortization of intangibles | 530 | 530 | 530 | 1,590 | 1,590 | |||||
Reduction in workforce | - | - | - | - | 221 | |||||
Non-GAAP gross profit subscription | $ | 24,397 | $ | 23,982 | $ | 26,889 | $ | 73,256 | $ | 82,270 |
GAAP gross margin subscription | 74.4 | % | 74.4 | % | 76.5 | % | 74.5 | % | 74.6 | % |
Non-GAAP gross margin subscription | 77.2 | % | 77.0 | % | 78.9 | % | 77.2 | % | 77.1 | % |
GAAP gross profit (loss) professional services | $ | (512) | $ | 294 | $ | (2,865) | $ | (1,926) | $ | (9,175) |
Stock-based compensation | 145 | 184 | 171 | 565 | 431 | |||||
Reduction in workforce | - | - | - | - | 317 | |||||
Non-GAAP gross profit (loss) professional services | $ | (367) | $ | 478 | $ | (2,694) | $ | (1,361) | $ | (8,427) |
GAAP gross margin professional services | (16.2) | % | 6.6 | % | (284) | % | (18.2) | % | (318) | % |
Non-GAAP gross margin professional services | (11.6) | % | 10.7 | % | (267) | % | (12.9) | % | (292) | % |
GAAP gross profit | $ | 23,020 | $ | 23,445 | $ | 23,191 | $ | 68,768 | $ | 70,502 |
Impact of non-GAAP adjustments | 1,010 | 1,015 | 1,004 | 3,127 | 3,341 | |||||
Non-GAAP gross profit | $ | 24,030 | $ | 24,460 | $ | 24,195 | $ | 71,895 | $ | 73,843 |
GAAP gross margin | 66.2 | % | 65.9 | % | 66.1 | % | 65.2 | % | 64.3 | % |
Non-GAAP gross margin | 69.1 | % | 68.7 | % | 69.0 | % | 68.2 | % | 67.4 | % |
Operating expense: | ||||||||||
GAAP sales and marketing | $ | 7,079 | $ | 7,208 | $ | 6,158 | $ | 21,200 | $ | 24,313 |
Stock-based compensation | (483) | (442) | (282) | (1,275) | (1,702) | |||||
Amortization of intangibles | (528) | (528) | (528) | (1,584) | (1,584) | |||||
Reduction in workforce | - | - | 2 | - | (332) | |||||
Non-GAAP sales and marketing | $ | 6,068 | $ | 6,238 | $ | 5,350 | $ | 18,341 | $ | 20,695 |
GAAP research and development | $ | 11,631 | $ | 12,316 | $ | 11,182 | $ | 36,060 | $ | 38,047 |
Stock-based compensation | (1,001) | (1,060) | (1,026) | (3,130) | (3,503) | |||||
Reduction in workforce | - | - | (5) | - | (663) | |||||
Certain legal expenses | - | - | - | - | 191 | |||||
Capitalization of internally developed software | - | - | - | - | 21 | |||||
Non-GAAP research and development | $ | 10,630 | $ | 11,256 | $ | 10,151 | $ | 32,930 | $ | 34,093 |
GAAP general and administrative | $ | 6,195 | $ | 6,366 | $ | 6,341 | $ | 18,927 | $ | 19,257 |
Stock-based compensation | (1,315) | (1,262) | (1,401) | (3,772) | (3,325) | |||||
Amortization of intangibles | - | - | - | - | (17) | |||||
Reduction in workforce | - | - | 15 | - | (482) | |||||
Non-GAAP general and administrative | $ | 4,880 | $ | 5,104 | $ | 4,955 | $ | 15,155 | $ | 15,433 |
GAAP goodwill impairment | $ | - | $ | - | $ | - | $ | - | $ | 50,300 |
Goodwill impairment | - | - | - | - | (50,300) | |||||
Non-GAAP goodwill impairment | $ | - | $ | - | $ | - | $ | - | $ | - |
GAAP operating expense | $ | 24,905 | $ | 25,890 | $ | 23,681 | $ | 76,187 | $ | 131,917 |
Impact of non-GAAP adjustments | (3,327) | (3,292) | (3,225) | (9,761) | (61,696) | |||||
Non-GAAP operating expense | $ | 21,578 | $ | 22,598 | $ | 20,456 | $ | 66,426 | $ | 70,221 |
Operating income (loss): | ||||||||||
GAAP operating loss | $ | (1,885) | $ | (2,445) | $ | (490) | $ | (7,419) | $ | (61,415) |
Impact of non-GAAP adjustments | 4,337 | 4,307 | 4,229 | 12,888 | 65,037 | |||||
Non-GAAP operating income | $ | 2,452 | $ | 1,862 | $ | 3,739 | $ | 5,469 | $ | 3,622 |
Net income (loss) and net income (loss) per share: | ||||||||||
GAAP net loss | $ | (2,032) | $ | (2,389) | $ | (447) | $ | (7,417) | $ | (60,986) |
Total pre-tax impact of non-GAAP adjustments | 4,337 | 4,307 | 4,229 | 12,888 | 65,037 | |||||
Non-GAAP net income | $ | 2,305 | $ | 1,918 | $ | 3,782 | $ | 5,471 | $ | 4,051 |
GAAP net loss per share, basic and diluted | $ | (0.01) | $ | (0.02) | $ | - | $ | (0.05) | $ | (0.41) |
Non-GAAP net income per share, basic and diluted | $ | 0.01 | $ | 0.01 | $ | 0.02 | $ | 0.03 | $ | 0.03 |
Shares used in basic and diluted net loss per share computation | 161,103 | 158,951 | 152,146 | 158,961 | 150,372 |
Attachments
- Original document
- Permalink
Disclaimer
Castlight Health Inc. published this content on 02 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 November 2021 20:21:54 UTC.